From The Stage

The Difference Between Pharmacokinetics and Pharmacodynamics

Dr. Chad Briscoe
Posted by Dr. Chad Briscoe / / Pharmacokinetics

In the United States, the safety and efficacy of prescription and over-the-counter drugs are a top priority for our government, medical professionals, and pharmaceutical companies. The Food and Drug Administration (FDA) is responsible for protecting public health by ensuring that any and all available medications are safe for human consumption, especially with regard to approving new medications or deciding whether or not a drug should be taken off the market. That even includes veterinary drugs and biological products as well. The cost of creating and testing a single drug can…

NIH to Back CRISPR-Based Rapid COVID-19 Testing

Dr. Chad Briscoe
Posted by Dr. Chad Briscoe / / COVID-19

According to the Centers for Disease Control and Prevention (CDC), there are currently over 6.2 million confirmed cases of COVID-19 in the United States, and that number continues to rise for the time being. From wearing masks to sheltering-in-place, social distancing, and incessant hand-washing, every American has the ability to help our nation ebb the continued spread of the novel coronavirus. In addition to encouraging Americans to adopt strict sterilization habits and apply them to their daily routine, more aggressive and ambitious methods need to be implemented like increased COVID-19…

COVID-19 Employee Testing: Where to Begin?

Dr. Chad Briscoe
Posted by Dr. Chad Briscoe / / BioAgilytix Insight, COVID-19

Every employer realizes that protecting employees’ health is paramount right now, but with so many uncertainties they need confidence that their testing strategy is optimized for success. We take a close look at parameters to consider in building an effective, sustainable COVID-19 employee testing plan.